Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

47 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Active, not recruiting

Savolitinib vs. Sunitinib in MET-driven PRCC.

NCT03091192

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 59 locations
View Trial Details
Active, not recruiting

Real World Registry for Use of the Ion Endoluminal System

NCT06004440

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Orlando Health Orlando Regional Medical Center Orlando, Florida, United States
  • Ascension Alexian Brothers Elk Grove Village, Illinois, United States
  • Blessing Hospital Quincy, Illinois, United States
  • Kansas University Medical Center Kansas City, Kansas, United States
View all 16 locations
View Trial Details
Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Completed

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

NCT01968109

Conditions
Neoplasms, Neoplasms by Site
Locations
  • Local Institution - 0043 La Jolla, California, United States
  • Local Institution - 0053 Aurora, Colorado, United States
  • Local Institution - 0058 Tampa, Florida, United States
  • Local Institution - 0003 Chicago, Illinois, United States
View all 54 locations
View Trial Details
Completed

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

NCT03656718

Conditions
Neoplasms, Neoplasms by Site
Locations
  • Winship Cancer Institute. Atlanta, Georgia, United States
  • Local Institution - 0024 Rockville, Maryland, United States
  • Local Institution - 0020 Detroit, Michigan, United States
  • Local Institution - 0001 Charlotte, North Carolina, United States
View all 36 locations
View Trial Details

Related conditions